EP265: The What, the How, and the Questionable Why of Digital Therapeutic Formularies, With Randy Vogenberg, PhD
March 19, 2020
265
29:26

EP265: The What, the How, and the Questionable Why of Digital Therapeutic Formularies, With Randy Vogenberg, PhD

There is a lot going on with digital health tools these days. Which ones are the good ones and which ones are nothing burgers packaged up in beautiful marketing? That’s a good question, and it would be nice to have a go-to source for such information.

Some parties — mainly PBMs [pharmacy benefit managers] and to some extent payers and providers — recognize that this actually would be nice, and they see that creating digital formularies could be an opportunity to grow revenue for their shareholders by meeting a market need potentially and offering additional services to the marketplace. But the term formulary implies more than just some kind of health technology assessment. It implies, at least at some level, the promise of reimbursement.

But given how local health care tends to be, especially when considering patient populations and the “bottom-up” nature of the doctor-patient relationship, here’s the question I have for you: Is it even possible for a third party, disconnected from the care setting and the patient, to “top-down” select the technology which will be used and reimbursed … especially in the age of consumerism?

For more on the intersection of patients and provider digital tool selections, listen to episode 250 with Vicky Tiase from NewYork-Presbyterian. 

In this health care podcast, I am speaking with Randy Vogenberg, PhD. Randy suggests that a more crowdsourced approach to digital health tool selection might be in order here. He says that those who are using the tools really need to have a seat at the table. He says that possibly the “formulary” within any given organization should be more of a consensus among stakeholders and less of a mandate from on high.

But there are a lot of wrinkles … like, lots of wrinkles.

Randy Vogenberg is board chairperson at the Employer-Provider Interface Council. He is principal over at the Institute for Integrated Healthcare.

You can learn more at iih-online.com, epicouncil.org, and hope.rutgers.edu

Randy Vogenberg, PhD, is principal at the Institute for Integrated Healthcare, co-leader for the National Employer Initiative on Specialty Pharmacy, and cofounder of the National Institute of Collaborative Healthcare (NICH). He is a health care expert on health system delivery and economics as well as health-related solution innovation research. Most recently he partnered with the Hospital Quality Foundation in developing the Employer-Provider Interface Council (EPIC). His broad hospital and managed care expertise includes current or future trends around financing, market excellence, and benefit management or design.

A leader and highly requested speaker on applied health systems research, he has authored programs or books on self-funded health benefits, managed markets, hospitals, and integrated medical-pharmacy benefit management. His academic relationships include Rutgers HOPE Center and former senior fellow at the Jefferson School of Population Health. Currently, he is an adjunct professor at the University of Rhode Island College of Pharmacy and Presbyterian College School of Pharmacy as well as the University of Illinois College of Pharmacy.


02:51 What a digital formulary is.
03:52 PBMs and digital formularies.
04:41 The changing landscape of PBMs and digital health.
06:00 The intersection of PBMs and digital health tools.
10:18 “Arbitrage, full on.”—Mark Blum, from America’s Agenda.
12:21 The inherent differences between a health plan and a PBM.
15:58 The original purpose of a pharmacy/therapeutics committee.
16:58 “There’s a lot of change happening, is the bottom line.”
18:18 The risk assessment behind medical software.
18:29 Harm vs digital therapeutics and digital medicine.
18:52 Cybersecurity in digital therapeutics.
19:08 Reimbursement in digital therapeutics.
19:43 The question of “how” in reimbursement.
20:37 “How do we reset health care in just one state, let alone the whole country?”
22:13 Taxpayers, patients, and employers vs the health care industry.
22:56 The slow move away from fee for service, and why.
24:13 The timeline for incorporating digital tools into the health care system.
24:33 “It’s a real problem for the consumer side.”
25:09 “What’s really going to be worthy of reimbursement?”
25:50 “There’s only two major payers in the health care system … that’s the government, and it’s the private sector employers and state programs or unions.”

You can learn more at iih-online.com, epicouncil.org, and hope.rutgers.edu

healthcare,healthtech,digitalhealth,digital health tools,PBMS,national employer initiative on specialty pharmacy,national institute of collaborative healthcare,nich,digital formularies,
|
|

Episode Support Provided By

Special Thanks to Our 2026 Sustaining Monthly Donors

Marilyn Bartlett, Kimberly Carleson, Dylan Yahn, Benjamin Light, Matt McQuideAnn Kempski, Spencer Allen, Scott Tromanhauser, 
Steven Elkins, Matthew Bunte, and Lori Smith.

Recent Episodes

EP525: PMPM vs FFS—The Perverse Incentives Plan Sponsors Sometimes Miss, With Cristin Dickerson, MD
Relentless Health ValueAugust 19, 2026
525
16:3315.14 MB

EP525: PMPM vs FFS—The Perverse Incentives Plan Sponsors Sometimes Miss, With Cristin Dickerson, MD

Listen on Your Favorite App So, this one's gonna be a little bit different. Back last year, I sat down with Dr. Cristin Dickerson. She is the founding partner of Green Imaging , which is a physician-led radiology network doing direct contracting for imaging. And we talked about how imaging can run 6...

EP524: Beating Provider Network Pricing Games by Thinking About Buying Healthcare Like a Manufacturer Supply Chain, With John Quinn
Relentless Health ValueAugust 12, 2026
524
17:0215.59 MB

EP524: Beating Provider Network Pricing Games by Thinking About Buying Healthcare Like a Manufacturer Supply Chain, With John Quinn

Listen on Your Favorite App Hello, all you Relentless Tribe members. First off here, I would like to thank Casey Cormier for the really nice recurring donation. Thank you so much, Casey Cormier from  Stratis Group . Lately, traditional provider networks are increasingly being called into questi...

EP523: The Sleeping Giants of Healthcare—Why Self-insured Employers and Clinicians Keep Missing Each Other, With Suhas Gondi, MD, MBA
Relentless Health ValueAugust 05, 2026
523
35:1632.28 MB

EP523: The Sleeping Giants of Healthcare—Why Self-insured Employers and Clinicians Keep Missing Each Other, With Suhas Gondi, MD, MBA

Listen on Your Favorite App Hello, all you Relentless Tribe members. Before we dive in today, I just wanted to give a quick but massive thank you to Alex Sommers, MD, ABEM, DipABLM, from Astia Health for his generous gift, which we are going to use to help fund a camera for the podcast here to level...

EP522: How Exactly Does GoodRx Make Money? With Ge Bai, PhD, CPA
Relentless Health ValueJuly 29, 2026
522
13:4512.58 MB

EP522: How Exactly Does GoodRx Make Money? With Ge Bai, PhD, CPA

Listen on Your Favorite App Arielle Bose: Hi, Stacey. This is Arielle Bose from EHD Insurance . Big fan of the podcast. We were talking about GoodRx the other day, and it occurred to me that I’m not exactly clear about how they make money. So, Stacey, how does GoodRx make money? For a full transcrip...

EP521: How Revenue Cycle Management (RCM) Became an Over $200 Billion Healthcare Hot Potato, With Andrew Tsang
Relentless Health ValueJuly 22, 2026
521
36:1333.15 MB

EP521: How Revenue Cycle Management (RCM) Became an Over $200 Billion Healthcare Hot Potato, With Andrew Tsang

Listen on Your Favorite App Hey, welcome to Relentless Health Value. Okay … so, on today's show, we are talking about (Andrew Tsang and I) revenue cycle management, which—I say this with real affection—is maybe the least sexy phrase in all of healthcare. It sounds like a back-office spreadsheet prob...

EP520: Cash-Pay Generic Drugs Are a Functioning Market in Healthcare—Policymakers Beware and Be Careful
Relentless Health ValueJuly 15, 2026
520
32:1829.56 MB

EP520: Cash-Pay Generic Drugs Are a Functioning Market in Healthcare—Policymakers Beware and Be Careful

Listen on Your Favorite App In the pachinko machine that is the healthcare industry, with just so many intermediaries, with so much regulatory capture and conflicts of interest that may or may not be visible, so much margin that is shrouded in mystery in an ecosystem as messy as this with so many va...

EP519: The Current State of Primary Care—Inevitable or Fixable? With Lisa Rosenbaum, MD
Relentless Health ValueJuly 08, 2026
519
40:0036.61 MB

EP519: The Current State of Primary Care—Inevitable or Fixable? With Lisa Rosenbaum, MD

Listen on Your Favorite App Hello, all you Relentless Tribe members. Today, let's start here. Right now, we are watching a very visible exodus of brilliant, consummate primary care (and other, honestly) physicians leaving traditional practice for concierge medicine or otherwise. For a full transcrip...

Listen and Follow

Sponsored by Aventria Health Group
©2026 BD Bridges LLC. All Rights Reserved.